Episode Overview

Title: Medicare Advantage Faces Rare Decline and Rising Market Pressures with Jakob Emerson
Podcast: Becker’s Healthcare Podcast
Date: October 11, 2025
Host: Scott Becker
Guest: Jakob Emerson, Healthcare Journalist & Payer Industry Expert

This episode dives into an unprecedented, projected decline in Medicare Advantage (MA) enrollment—a notable shift after two decades of consistent growth. Jakob Emerson discusses the key reasons behind this change, its impact on payers and providers, regional market consequences, and evolving strategies among health plans. The episode also addresses intensifying payer-provider tensions, the future outlook for MA, and how current political and policy events, like the government shutdown, are poised to influence healthcare markets.

Key Discussion Points & Insights

1. A Rare Decline in Medicare Advantage Enrollment

• [00:23] Jakob Emerson outlines new CMS projections: Medicare Advantage enrollment will drop by nearly 1 million in 2026, from 35 million to 34 million. This marks the first significant national contraction in MA’s history.

  • "Medicare Advantage enrollment is expected to decline next year, which is a pretty rare reversal for the program that...has expanded rapidly for the last two decades." (Jakob Emerson, 00:24)

• Market Context: For years, MA has been one of the most profitable and competitive areas for insurers.

  • This decline is viewed as a turning point after years of steady growth.

2. Causes of the Slowdown: Profitability and Payer Retrenchment

• [01:14] Scott Becker suggests that the decline is driven more by profitability concerns and payer pullback than by declining consumer demand.

• [01:51] Emerson agrees, attributing the contraction to multiple market pressures:

  • Rising post-pandemic healthcare utilization and costs
  • Tighter federal cost-containment policies and more CMS audits
  • Increased reimbursement friction between payers and hospitals
  • Smaller insurers—especially regional and nonprofit MA plans—are pulling out of markets or shutting down their MA lines entirely.
  • "It’s the small regional Blue Cross plans, some of the nonprofit insurers...some of them are literally shutting down their entire Medicare business going into next year." (Jakob Emerson, 04:38)

• Geographic Impact: In some states, large swaths of counties will lose all MA plan options, prompting some to call it a “Medicare Advantage market collapse.” Still, 99% of beneficiaries will have at least one MA plan.

3. Changing Market Share and Sentiment

• [03:26] Medicare Advantage had surged to about 54-55% of all Medicare enrollment, but with the decline, could dip closer to 50%.

  • Seniors have mixed opinions, while providers are "increasingly negative toward Medicare Advantage." (Scott Becker, 03:26)
  • Payers "go with the flow"—investing heavily only when profits are strong.

• [04:10] The federal government remains interested in expanding MA, but is constrained by both market realities and its own regulatory pressures.

4. Intensifying Provider-Payer Tensions

• [05:18] Emerson highlights more contentious provider-insurer negotiations:
  • Examples: UnitedHealthcare is now out-of-network with Johns Hopkins (Baltimore) and all Ascension facilities in Wisconsin (impacting over 1,000 physicians).
  • Hospital executives are dealing with these standoffs personally—direct phone calls between hospital CFOs/RCM leads and payer executives are now vital for resolving disputes.
  • "In a time of extreme financial tension, personal relationships are mattering more than ever between the executives on both sides." (Jakob Emerson, 06:42)

5. Not All Insurers are Retreating

• [07:26] Despite market pressure, some larger insurers see a long-term opportunity in MA, due to America’s aging demographics (10,000 people a day become Medicare-eligible).
  • Health Care Service Corporation (parent company of multiple Blue Cross plans) is buying Cigna’s Medicare business for $3 billion.
  • Some not-for-profit plans—like SCAN Group and larger health system-owned insurers (Intermountain, Providence)—are committed to growing their market share.
  • Still, "the vast majority of insurers are not having an easy time in Medicare Advantage despite some of these outliers." (Jakob Emerson, 08:36)

Notable Quotes & Memorable Moments

• "We're seeing rising medical costs in general, a lot more seniors are coming back for healthcare services post pandemic...as a result, we're seeing these market exits."
  — Jakob Emerson, [01:55]

• "In some states, it’s been described as a Medicare Advantage market collapse by insurance regulators."
  — Jakob Emerson, [02:56]

• "Hospital executives...are leaning more on personal relationships with executives on the other side...trying to have more personal relations to get contracts in place or just little things, little margin increases."
  — Jakob Emerson, [06:28]

• "Even if the current market is difficult to be profitable and sustainable within, [Medicare Advantage] is a massive business opportunity for decades to come."
  — Jakob Emerson, [07:41]

Timestamps for Important Segments

• 00:23: CMS announcement—projected decline in MA enrollment
• 01:14: Causes of decline, profitability pressures, plan retrenchment
• 03:26: Shift in market share, provider/payer/provider attitudes
• 04:35: Smaller insurers/regionals shutting down MA
• 05:18: Escalating provider-payer tensions; UnitedHealthcare out-of-network standoffs
• 06:28: The growing importance of personal relationships in contract negotiations
• 07:26: Outlier insurers still investing in MA (HCSC, SCAN, health system-owned plans)
• 08:47: Outlook—changing projections and top policy concerns

Policy & Political Environment

• [09:08] Legislative and regulatory developments to watch:
  • Potential impacts of the ongoing government shutdown on federal healthcare operations
  • The status of ACA enhanced subsidies
  • Continued monitoring of No Surprises Act implementation and regulatory oversight

Conclusion

Takeaway:
The projected contraction in Medicare Advantage enrollment is a pivotal moment, driven by rising costs, regulatory scrutiny, and a wave of smaller insurer exits. While major payers with resources and regional dominance are doubling down for the long haul, most players are retrenching. Meanwhile, the battle lines between providers and payers are sharpening, with more deals now brokered on the strength of individual executive relationships amidst financial strain. The episode concludes with a nod to political uncertainty and its continued influence on healthcare’s next moves.